NMC Health (NMC) Given “Buy” Rating at Berenberg Bank
Separately, Jefferies Group restated a hold rating and issued a GBX 2,810 ($37.82) target price on shares of NMC Health in a research report on Wednesday, November 15th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company presently has a consensus rating of Buy and an average price target of GBX 2,522 ($33.94).
Shares of NMC Health (NMC) traded up GBX 79 ($1.06) during mid-day trading on Wednesday, reaching GBX 2,817 ($37.91). 374,802 shares of the company traded hands, compared to its average volume of 314,074. NMC Health has a one year low of GBX 1,500 ($20.19) and a one year high of GBX 3,211 ($43.22).
TRADEMARK VIOLATION WARNING: “NMC Health (NMC) Given “Buy” Rating at Berenberg Bank” was originally reported by Watch List News and is the property of of Watch List News. If you are reading this story on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://www.watchlistnews.com/nmc-health-nmc-given-buy-rating-at-berenberg-bank/1776410.html.
NMC Health Company Profile
NMC Health plc is a private healthcare services provider in the United Arab Emirates. The Company operates through two segments: healthcare and distribution & services. The healthcare segment is engaged in providing professional medical services, comprising diagnostic services, in and outpatient clinics, provision of all types of research and medical services in the field of gynecology, obstetrics and human reproduction and retailing of pharmaceutical goods.
Receive News & Ratings for NMC Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NMC Health and related companies with MarketBeat.com's FREE daily email newsletter.